| Dr Collin Thomas Atkinson, PT | |
|
11724 Seward Hwy, Suite G, Seward, AK 99664-9708 | |
| (907) 224-7848 | |
| (907) 224-7849 |
| Full Name | Dr Collin Thomas Atkinson |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 11724 Seward Hwy, Seward, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942754742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT60670784 (Washington) | Secondary |
| 225100000X | Physical Therapist | 114699 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kenaitze Indian Tribe | 4082506225 | 18 |
News Archive
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
Loneliness is a major risk factor in increasing blood pressure in older Americans, and could increase the risk of death from stroke and heart disease, new research at the University of Chicago shows.
Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals.
BODY image identity varies among women who have undergone treatment for breast cancer with many rejecting mainstream body shape ideals, research shows.
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.
› Verified 8 days ago
| Provider Name | Kenaitze Indian Tribe |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932114600 PECOS PAC ID: 4082506225 Enrollment ID: O20040325000198 |
News Archive
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
Loneliness is a major risk factor in increasing blood pressure in older Americans, and could increase the risk of death from stroke and heart disease, new research at the University of Chicago shows.
Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals.
BODY image identity varies among women who have undergone treatment for breast cancer with many rejecting mainstream body shape ideals, research shows.
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.
› Verified 8 days ago
| Provider Name | Advanced Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437214459 PECOS PAC ID: 0941228548 Enrollment ID: O20051102000678 |
News Archive
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
Loneliness is a major risk factor in increasing blood pressure in older Americans, and could increase the risk of death from stroke and heart disease, new research at the University of Chicago shows.
Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals.
BODY image identity varies among women who have undergone treatment for breast cancer with many rejecting mainstream body shape ideals, research shows.
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Collin Thomas Atkinson, PT 508 Upland St, Kenai, AK 99611-8026 Ph: (907) 335-7513 | Dr Collin Thomas Atkinson, PT 11724 Seward Hwy, Suite G, Seward, AK 99664-9708 Ph: (907) 224-7848 |
News Archive
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).
Loneliness is a major risk factor in increasing blood pressure in older Americans, and could increase the risk of death from stroke and heart disease, new research at the University of Chicago shows.
Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals.
BODY image identity varies among women who have undergone treatment for breast cancer with many rejecting mainstream body shape ideals, research shows.
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.
› Verified 8 days ago
Shelbylee Harris, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 234 4th Ave, Suite 100, Seward, AK 99664 Phone: 907-224-7848 | |
Christina Esbenshade, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 417 1st Avenue, Seward, AK 99664 Phone: 907-224-5205 | |
Mark Paul Ifflander, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 417 1 St. Ave., Seward, AK 99664 Phone: 907-224-2800 | |
Patricia A Beals, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 417 First Ave, Seward, AK 99664 Phone: 907-224-2800 | |
Elizabeth Dierkes, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 234 Fourth Ave Ste 100, Seward, AK 99664 Phone: 866-238-1168 |